Table 2.
Groups | Dosage g/kg | N | Thymus index (mg/g) | Spleen index (mg/g) | Liver index (mg/g) | Kidney index (mg/g) |
---|---|---|---|---|---|---|
Control | - | 8 | 3.965±0.123 | 5.864±1.989 | 467.457±189.841 | 14.4509±4.473 |
Model | - | 8 | 3.502±0.163ac | 5.033±2.624ac | 492.436±364.409c | 13.913±3.880ac |
5-FU | 0.03 | 8 | 2.469±0.140ab | 3.212±1.103ab | 637.620±471.837ab | 14.384±5.538b |
5-FU+ASMq.H | 8 | 8 | 3.174±0.087abc | 4.256±1.928abc | 547.370±186.089abc | 12.637±3.249abc |
5-FU+ASMq.M 4 | 4 | 8 | 3.862±0.088bc | 5.699±1.435bc | 504.413±109.636ac | 13.981±2.884ac |
5-FU+ASMq.L | 2 | 8 | 3.112±0.161abc | 4.148±1.872abc | 519.447±244.387abc | 13.960±5.482ac |
VS control group,a P<0.05;VS model group, b P<0.05。VS 5-FU group, c P<0.05